Authors: Churchill, DR Slade, PM Youle, M Gazzard, BG Wcber, JN

Citation: Dr. Churchill et al., A phase I/II study of the safety and activity of a microsphere formulationof KNI-272 in patients with HIV-1 infection, J ANTIMICRO, 47(3), 2001, pp. 353-355

Authors: Clarke, JR Galpin, S Braganza, R Ashraf, A Russell, R Churchill, DR Weber, JN McClure, MO

Citation: Jr. Clarke et al., Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients, J MED VIROL, 62(4), 2000, pp. 445-449

Authors: Chen, F Kearney, T Robinson, S Daley-Yates, PT Waldron, S Churchill, DR

Citation: F. Chen et al., Cushing's syndrome and severe adrenal suppression in patients treated withritonavir and inhaled nasal fluticasone, SEX TRANS I, 75(4), 1999, pp. 274-274

Authors: Churchill, DR Pym, AS Galpin, S Foxall, R Stainsby, C Clarke, JR Kaye, S Bloor, S Larder, BA Wills, B Sun, E Babiker, AG Back, DJ Weber, JN

Citation: Dr. Churchill et al., The rabbit study: Ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patients, AIDS RES H, 15(13), 1999, pp. 1181-1189